Applied DNA Sciences (APDN) Tops Q2 EPS by 3c
Get Alerts APDN Hot Sheet
Price: $5.00 --0%
Revenue Growth %: -78.1%
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -78.1%
Financial Fact:
Research and development: 1.41M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.3 million.
Excluding non-cash expenses, Adjusted EBITDA for the three months ended March 31, 2015 would have been a negative $1.2 million compared to a negative Adjusted EBITDA of $2.6 million for the same quarter last year and a negative Adjusted EBITDA of $1.7 million for our prior fiscal quarter.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Business First Bancshares, Inc. (BFST) Misses Q1 EPS by 7c
- Applied DNA Sciences (APDN) Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!